Trial
NCT04509999
Bicalutamide to Block TMPRSS2 in Males With COVID-19 Infection
Phase IIIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Florida
Collaborators
—
Condition
COVID-19
Intervention
Bicalutamide 150 Mg Oral Tablet
Why stopped
No patients enrolled and funding withdrawn
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-07-01